UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aberrant expression of sialidase and cancer progression

Proceedings of the Japan Academy, Series B, 2008/12/30, Vol.84(10), pp.407-418

MIYAGI, Taeko

2008

Volltextzugriff (PDF)

Biological and Pathological Roles of Ganglioside Sialidases

Progress in molecular biology and translational science, 2018, Vol.156, p.121

2018

Volltextzugriff (PDF)

Rapid Trimming of Cell Surface Polysialic Acid (PolySia) by Exovesicular Sialidase Triggers Release of Preexisting Surface Neurotrophin

The Journal of biological chemistry, 2015-05, Vol.290 (21), p.13202-13214

2015

Volltextzugriff (PDF)

The sialidase inhibitor 2,3-dehydro-2-deoxy-N-acetylneuraminic acid is a glucose-dependent potentiator of insulin secretion

Scientific reports, 2020-03, Vol.10 (1), p.5198-5198, Article 5198

2020

Volltextzugriff (PDF)

Regulation of Sialyl Lewis Antigen Expression in Colon Cancer Cells by Sialidase NEU4

The Journal of biological chemistry, 2011-06, Vol.286 (24), p.21052-21061

2011

Volltextzugriff (PDF)

Structural basis for substrate specificity of mammalian neuraminidases

PloS one, 2014-09, Vol.9 (9), p.e106320-e106320

2014

Volltextzugriff (PDF)

Prognostic model for patients with advanced cancer using a combination of routine blood test values

Supportive care in cancer, 2021-08, Vol.29 (8), p.4431-4437

2021

Volltextzugriff (PDF)

Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum

Cancer science, 2015-04, Vol.106 (4), p.383-389

2015

Volltextzugriff (PDF)

Plasma membrane‐associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane‐treated transgenic mice

Cancer science, 2009-04, Vol.100 (4), p.588-594

2009

Volltextzugriff (PDF)

Sialidase NEU3 defines invasive potential of human glioblastoma cells by regulating calpain-mediated proteolysis of focal adhesion proteins

Biochimica et biophysica acta. General subjects, 2017-11, Vol.1861 (11), p.2778-2788

2017

Volltextzugriff (PDF)

Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer

Biomedicines, 2024-01, Vol.12 (1), p.192

2024

Volltextzugriff (PDF)

Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages

Journal of the American Heart Association, 2021-02, Vol.10 (4), p.e018756

2021

Volltextzugriff (PDF)

Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis

Cancer science, 2015-11, Vol.106 (11), p.1544-1553

2015

Volltextzugriff (PDF)

Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling

International journal of cancer, 2015-10, Vol.137 (7), p.1560-1573

2015

Volltextzugriff (PDF)

Limited Inhibitory Effects of Oseltamivir and Zanamivir on Human Sialidases

Antimicrobial Agents and Chemotherapy, 2008-10, Vol.52 (10), p.3484-3491

2008

Volltextzugriff (PDF)

Review sialidase NEU3 and its pathological significance

Glycoconjugate journal, 2022-10

2022

Volltextzugriff (PDF)

Structure and Function of Mammalian Sialidases

Topics in current chemistry, 2015, Vol.366, p.183

2015

Volltextzugriff (PDF)

Reduced susceptibility to colitis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidase

PloS one, 2012-07, Vol.7 (7), p.e41132

2012

Volltextzugriff (PDF)

Human cytosolic sialidase NEU2-low general tissue expression but involvement in PC-3 prostate cancer cell survival

Biochemical and biophysical research communications, 2012-11, Vol.428 (1), p.142-149

2012

Volltextzugriff (PDF)

Mammalian Sialidases and Their Functions

Trends in glycoscience and glycotechnology, 2010, Vol.22 (125), p.162-172

Miyagi, Taeko

2010

Volltextzugriff (PDF)

Stereocontrolled and Convergent Entry to CF2-Sialosides: Synthesis of CF2-Linked Ganglioside GM4

Journal of the American Chemical Society, 2007-12, Vol.129 (50), p.15420-15421

2007

Volltextzugriff (PDF)

Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation

PloS one, 2015-03, Vol.10 (3), p.e0120578

2015

Volltextzugriff (PDF)

Down‐regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers

Cancer science, 2007-03, Vol.98 (3), p.299-307

2007

Volltextzugriff (PDF)

Loss of Cellular Sialidases Does Not Affect the Sialylation Status of the Prion Protein but Increases the Amounts of Its Proteolytic Fragment C1

PloS one, 2015-11, Vol.10 (11), p.e0143218

2015

Volltextzugriff (PDF)

Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides

Cancer science, 2011-12, Vol.102 (12), p.2139-2149

2011

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(157)

Publikationsform

Artikel
(181)
Buchkapitel
(2)

Sprache

Englisch
(169)
Japanisch
(88)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aberrant expression of sialidase and cancer progression

Biological and Pathological Roles of Ganglioside Sialidases

Rapid Trimming of Cell Surface Polysialic Acid (PolySia) by Exovesicular Sialidase Triggers Release of Preexisting Surface Neurotrophin

The sialidase inhibitor 2,3-dehydro-2-deoxy-N-acetylneuraminic acid is a glucose-dependent potentiator of insulin secretion

Regulation of Sialyl Lewis Antigen Expression in Colon Cancer Cells by Sialidase NEU4

Structural basis for substrate specificity of mammalian neuraminidases

Prognostic model for patients with advanced cancer using a combination of routine blood test values

Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum

Plasma membrane‐associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane‐treated transgenic mice

Sialidase NEU3 defines invasive potential of human glioblastoma cells by regulating calpain-mediated proteolysis of focal adhesion proteins

Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer

Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages

Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis

Sialidase NEU3 contributes neoplastic potential on colon cancer cells as a key modulator of gangliosides by regulating Wnt signaling

Limited Inhibitory Effects of Oseltamivir and Zanamivir on Human Sialidases

Review sialidase NEU3 and its pathological significance

Structure and Function of Mammalian Sialidases

Reduced susceptibility to colitis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidase

Human cytosolic sialidase NEU2-low general tissue expression but involvement in PC-3 prostate cancer cell survival

Mammalian Sialidases and Their Functions

Stereocontrolled and Convergent Entry to CF2-Sialosides: Synthesis of CF2-Linked Ganglioside GM4

Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation

Down‐regulation of sialidase NEU4 may contribute to invasive properties of human colon cancers

Loss of Cellular Sialidases Does Not Affect the Sialylation Status of the Prion Protein but Increases the Amounts of Its Proteolytic Fragment C1

Membrane sialidase NEU3 is highly expressed in human melanoma cells promoting cell growth with minimal changes in the composition of gangliosides

Suchergebnisse filtern